Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

导出 LinkOut

翻译打印收藏纠错

作者： M,Deraco ^[1] ; D,Baratti ; B,Laterza ; M R,Balestra ; E,Mingrone ; Antonio,Macrì ; S,Virzì ; F,Puccio ; P S,Ravenda ; S,Kusamura

作者单位： Department of Surgery, Peritoneal Surface Malignancies Branch, National Cancer Institute, Via Venezian no. 1, Milan, Italy. marcello.deraco@istitutotumori.mi.it ^[1]

主题词抗肿瘤药(Antineoplastic Agents);综合疗法(Combined Modality Therapy);女(雌)性(Female);人类(Humans);高温, 诱发(Hyperthermia, Induced);输注, 胃肠外(Infusions, Parenteral);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);卵巢肿瘤(Ovarian Neoplasms);护理标准(Standard of Care)

DOI 10.1016/j.ejso.2010.11.004

PMID 21112721

发布时间 2019-02-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览70

European journal of surgical oncology

2011年37卷1期

4-9页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

European journal of surgical oncology

相似文献

European journal of surgical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

European journal of surgical oncology

相似文献

European journal of surgical oncology

相关期刊

检索历史清除